Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions

D. Makris, A. Scherpereel, S. Leroy, B. Bouchindhomme, J-B. Faivre, J. Remy, P. Ramon, C-H. Marquette
European Respiratory Journal 2007 29: 1187-1192; DOI: 10.1183/09031936.00165306
D. Makris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Scherpereel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Leroy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B. Bouchindhomme
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J-B. Faivre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Remy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. Ramon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C-H. Marquette
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The present study prospectively evaluated the diagnostic yield and safety of electromagnetic navigation-guided bronchoscopy biopsy, for small peripheral lung lesions in patients where standard techniques were nondiagnostic.

The study was conducted in a tertiary medical centre on 40 consecutive patients considered unsuitable for straightforward surgery or computed tomography (CT)-guided transthoracic needle aspiration biopsy, due to comorbidities. The lung lesion diameter was mean±sem 23.5±1.5 mm and the depth from the visceral-costal pleura was 14.9±2 mm. Navigation was facilitated by an electromagnetic tracking system which could detect a position sensor incorporated into a flexible catheter advanced through a bronchoscope. Information obtained during bronchoscopy was superimposed on previously acquired CT data. Divergence between CT data and data obtained during bronchoscopy was calculated by the system's software as a measure of navigational accuracy.

All but one of the target lesions was reached and the overall diagnostic yield was 62.5% (25–40). Diagnostic yield was significantly affected by CT-to-body divergence; yield was 77.2% when estimated divergence was ≤4 mm. Three pneumothoraces occurred and chest drainage was required in one case.

Electromagnetic navigation-guided bronchoscopy has the potential to improve the diagnostic yield of transbronchial biopsies without additional fluoroscopic guidance, and may be useful in the early diagnosis of lung cancer, particularly in nonoperable patients.

  • Bronchoscopy
  • computed tomography
  • pulmonary nodule
  • three-dimensional imaging

Lung cancer is still a leading cause of cancer mortality with an overall 5-yr survival of <20% in Europe and in the USA 1. The main reason of low survival rates and treatment failure is late diagnosis of extensive disease. The stage of disease at diagnosis still represents one of the most powerful determinants of outcome in lung cancer 2. In this respect, a number of studies have suggested that small lung cancers, which are potentially resectable, can be identified using computed tomography (CT) screening programmes 3, 4. Nonetheless, this diagnostic advance will not be applicable if current management cannot overcome two related problems. First, the high proportion of false-positive CT findings may reach 70% 5 and thus, histological confirmation is essential for diagnosis. Secondly, a significant proportion of early-stage lung cancer patients may be medically inoperable due to comorbid medical illness or poor pulmonary function 6. Therefore, a diagnostic procedure less invasive than surgery, such as transthoracic needle aspiration biopsy (TTNA) or bronchoscopy, is warranted to provide definitive diagnosis and to offer the prospect of cure in medically inoperable patients by the application of local treatment, such as radiation 7.

However, current nonsurgical techniques available to diagnose small peripheral lung lesions (SPLL) are limited either by low accuracy 8–11 or by potential complications 12–15. The diagnostic yield of bronchoscopy for such lesions may be <30% 10, 16, 17. However, although TTNA may reach a diagnostic yield of 82–96% 12, 13, it is associated with increased pneumothorax rates ranging 23–44% 18, 19. Furthermore, the high diagnostic yield of this method derives from selected populations that fulfil, in advance, the clinical and radiological criteria to undergo TTNA.

Novel methods aiming to improve the yield of bronchoscopy in pulmonary nodules have attracted clinical interest 20–22. Electromagnetic guided bronchosopy (EGB) can guide the biopsy of endobronchially invisible peripheral lesions. However, previous clinical studies either included small populations, in which the lesions were too inhomogeneous to draw definitive conclusions regarding yield and safety of the method 22, 23, or used additional fluoroscopic guidance for diagnosis 24. The purpose of the present study was to provide basic data about the diagnostic yield and the incidence of complications with respect to EGB biopsy of SPLL, for patients in which conventional bronchoscopy was not diagnostic and who were not eligible for straightforward curative surgery due to comorbitities.

METHODS

Patients

The study had a prospective open-label design. Consecutive sampling was used to recruit patients who attended outpatient clinics in the Albert Calmette University Hospital (Lille, France) between October 2005 and September 2006 and who met the following criteria: 1) peripheral pulmonary lesion (solid or fatty solid nodule located beyond the visible range of flexible bronchoscopy) detected by chest radiography and CT; 2) suspicion of cancer by CT morphology or positive positron emission tomography (PET) scan; 3) nondiagnostic conventional bronchoscopy; 4) absence of other metastatic lesions accessible for biopsy; 5) negative TTNA or contraindication for TTNA (severe pulmonary impairment, bleeding diathesis, lesions not accessible by TTNA as judged by a radiologist panel); 6) contraindication for straightforward curative surgery; or 7) if associated mediastinal lymph node transbronchial needle aspiration (TBNA) was negative or in case that lymph nodes were difficult to reach with TBNA. All cases presented were discussed in a weekly multidisciplinary meeting in the authors’ tertiary hospital where it was judged that, due to important comorbidities, they required treatment other than the typical surgical approach, considering the benefit–risk ratio for each individual case. The discussion of each case in this meeting was part of the inclusion process. Exclusion criteria for the present study included: 1) contraindication to short-acting anaesthetic agents; 2) bleeding diathesis; 3) presence of concomitant endobronchial lesion; 4) a pacemaker/defibrillator; or 5) a diagnosis by other means (sputum cytology, microbiology).

Follow-up included clinical assessment and erect postero-anterior chest radiographs immediately after biopsy, within 24 h and within 15 days for the evaluation of potential complications. Informed consent was obtained from all patients before conventional and EGB according to ethical principles and permission of the institutional review board.

CT

All patients underwent thoracic CT examinations prior to the bronchoscopy procedures. Recommended technical thoracic CT criteria for navigation software were: 1) slice thickness 2–3.5 mm; 2) slice interval (with overlap of 1 mm) 1–2.5 mm; 3) image size 512x512 pixels; and 4) dicom format. If thoracic CT performed during the initial diagnostic work-up did not fulfill the above criteria a new CT was performed.

EGB

The electromagnetic navigation system (superDimension/Bronchus, Hertzliya, Israel) and navigation procedures are described in detail in the supplementary data. Briefly, the system uses a sensor probe that picks up the electromagnetic field generated by a localisation system (a processor, amplifier and a location board). When the sensor was placed within the electromagnetic field, its position and orientation could be identified and this information was displayed on a monitor and superimposed upon previously acquired CT images. This image-guided localisation device aimed at guiding transbronchial biopsies in desired predetermined targets within the bronchial tree. Initially, the digitised information from each patient's CT scan was imported into the electromagnetic navigation system where axial, coronal and sagittal views of the chest and virtual endoscopy images were reconstructed. Consequently, anatomic landmarks (typically major bronchial tree bifurcations) were identified as coordinates on the corresponding CT as well as on the virtual bronchoscopy image (planning). The same identifiable landmarks were then used during real-time bronchoscopy in order to relate the CT data to the actual anatomy. When these points were touched with the sensor, they were simultaneously recorded by the navigation system (registration).

The system software had the ability to correlate pre-operative CT data and actual position, to display the estimated actual location of the target on screen and to provide a navigation scheme with which to approach the lesion. In addition, the system could calculate the divergence between data obtained pre-operatively by CT and data obtained during bronchoscopy (CT-to-body divergence), providing a measure of accuracy of electromagnetic navigation.

Flexible bronchoscopy (Pentax, Tokyo, Japan) was performed under general anaesthesia and was carried out by two experienced bronchoscopists, C-H. Marquette and P. Ramon (see supplementary data). Navigation aimed to closely approach the target lesion (distance between sensor tip and lesion centre ≤15 mm). Nine attempts for biopsy were scheduled for each lesion and, every three attempts, the forceps were withdrawn and the position of the sensor probe in relation to the target lesion was checked.

Statistical analysis

The primary efficacy end-point was whether the EGB biopsy resulted in the diagnosis of lung cancer or another lung pathology. Patients underwent additional diagnostic procedures (TTNA, surgery) or clinical and thoracic imaging follow-up, if EGB biopsy was inconclusive. When these additional procedures resulted in diagnosis of lung cancer or lung pathology, the cases were considered as nondiagnosed by EGB. The following formula was used to compute yield of EGB biopsy:

Diagnostic yield (%) = 100 x EGB biopsy diagnosed cases/total number of patients with completed procedures.

The yield of EGB was examined by lesion characteristics, CT-to-body divergence and bronchoscopy operator. The learning curve regarding the use of this technique was assessed by comparing the diagnostic yield achieved in the first sessions with the yield achieved in the last sessions, for each operator separately. Results are presented as mean±sem values for continuous data or as percentage for categorical data. Comparisons between groups of categorical data were performed using Fisher's exact and Chi-squared goodness of fit tests.

RESULTS

A total of 40 patients were enrolled in the study. Patients were aged 60±2.5 yrs and 30 out of 40 (75%) were male. A group of 12 patients had primarily severe cardiovascular problems, four had severe renal impairment (haemodialysis), 10 had severe obstruction (forced expiratory volume in one second 30.3±2.1% of predicted values), three had undergone lobectomy and the remaining eleven had mixed comorbidities (cardiovascular disease, diabetes, chronic obstructive pulmonary disease (COPD), hepatic failure, obesity). In nine patients, thoracic CT performed during the initial diagnostic work up did not fulfill technical criteria for navigation software and a new CT was performed.

The lesions had a size of 23.5±2 mm (range 8–49; table 1⇓). In total, 25 lesions were classified as T1 and 15 as T2 according to tumour, node, metastasis staging. The accuracy of the navigation process, as expressed by the average of CT-to-body divergence was 4±0.15 mm while the distance between sensor probe and centre (or perimeter) of the target lesion before each attempt for biopsy was 8.7±0.8 mm (or -3.8±1 mm). Figure 1⇓ shows the three-dimensional CT scan data appearance of a nodule with 28 mm diameter demonstrating navigational information for direction distance in a 64-yr-old patient.

Fig. 1—
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1—

a) Computed tomography (CT) image of a nodule (green circle) of 28 mm in diameter (blue arrow) in the posterior segment of the right upper lobe, taken with the patient in a supine position. Scale bar = 2 cm. b) Enlarged image of a). c) CT taken with the patient in an upright position, the nodule is 6 mm (blue arrow) from the chest wall. Scale bar = 1 cm. d) The distance from the tip of the sensor probe to the target is 8 mm. In total seven biopsies were performed, out of which six contained normal lung parenchyma and one was positive for squamous cell carcinoma. Pink arrows represent the tip of the sensor probe.

View this table:
  • View inline
  • View popup
Table 1—

Patient characteristics

EBG produced a diagnosis in 25 (62.5%) out of 40 cases. In 20 cases, the biopsies obtained showed cancer (10 adenocarcinoma and 10 squamous cell cancer) and in five cases biopsies demonstrated a benign disease/condition (two with tuberculosis, one sandblasting silicose, one noncaseating granuloma and one hamartoma) confirmed by surgery (n = 3), TTNA (n = 1) or clinical/CT examination at 14 months follow-up. In the remaining 15 cases, EGB biopsy was either not diagnostic (n = 14) or not feasible (n = 1). A group of 13 EGB nondiagnostic cases were malignant (nine with lung adenocarcinoma, two metastatic adenocarcinoma and two squamous cell cancer) and corresponded to exo-bronchial (n = 4), small (<12 mm; n = 2) extremely peripheral lesions (n = 3); for four cases no obvious explanation could be found. These cases were finally diagnosed by open lung biopsy (n = 8), mediastinoscopy (n = 2) or TTNA (n = 3). One patient with nondiagnostic biopsy did not complete the follow-up procedure and final diagnosis was not available. Biopsy was not feasible in the case of a 15 mm diameter peripheral nodule located in the apical segment of left lower lobe; the closest distance to target reached was 26 mm. PET was negative and CT showed regression of the lesion at 14 months follow-up.

The diagnostic yield of EGB for different influencing factors is shown in table 2⇓. The yield was significantly greater when the CT-to-body divergence was ≤4 mm (77.2 versus 44.4%; p = 0.03). The yield for T1 and T2 lesions was 56 and 73.3%, respectively; however, no statistical difference was noted between them. In addition, no significant learning curve was observed in these series of patients (table 2⇓). The sensitivity and negative predictive value of EBG for malignancy were 57 and 25%, respectively, assuming that the case which remained without diagnosis and the case where biopsy was not feasible were not benign (or 60.6 and 35%, respectively, assuming the two cases were benign).

View this table:
  • View inline
  • View popup
Table 2—

Diagnostic yield by lesion type, size, volume, location, computed tomography(CT)-to-body divergence and operator

In every lesion, 8.5±0.7 biopsies were attempted and 6.7±0.4 specimens per lesion were obtained. Among specimens obtained on site, 2±0.5 specimens per lesion (or 29±1% of specimens obtained) corresponded to clots, unidentifiable cellular casts or unrecognisable material and were judged as improper for evaluation. No significant differences were found between EGB diagnosed and EGB nondiagnosed cases in terms of number of biopsies attempted, specimens obtained and specimens analysed.

A 58-yr-old smoker with severe COPD presented with pneumothorax requiring chest drainage 5 h after bronchoscopy, while another two patients experienced small asymptomatic spontaneously resolved pneumothoraces immediately after procedure. No late adverse events were reported.

DISCUSSION

The current study is the first prospective study to demonstrate that electromagnetic navigation during flexible bronchoscopy increases the reliability of bronchoscopy for SPLL diagnosis without additional fluoroscopic assistance 22–24. The overall diagnostic yield of EGB for SPLL in this consecutive series of patients where standard diagnostic techniques failed in establishing diagnosis was 62.5%. Notably, when CT-to-body divergence, a measure of data registration accuracy, was ≤4 mm, the diagnostic yield reached 77.2%. This is superior to the yield of conventional bronchoscopic techniques for SPLL reported in most studies 8–11.

The yield of flexible bronchoscopy in nodular lung lesions ranges between 19 and 62% because it is greatly affected by both lesion size and location 7, 8, 11, 25, 26. Thus, in the study of Baaklini et al. 10, the yield for lesions <2 cm, which were located in the peripheral third of the lung, was 14%. Fluoroscopic guidance has been used to increase the sensitivity of bronchoscopy 27. However, fluoroscopy causes radiation exposure 28 and the yield is still affected by lesion characteristics 8, 9, 29. Alternative techniques, such as endobronchial ultrasound or CT-fluoroscopy, may significantly improve the diagnostic yield of conventional bronchoscopy 15, 21 but there are also drawbacks to these methods. Endobronchial ultrasound is costly, requires regular probe replacement and includes difficulty in selecting the bronchial branch of interest thus producing a lower yield in apical-posterior lobes. Conversely, radiation exposure for both staff and patients restricts the efficient application of CT-fluoroscopy 15. Therefore, electromagnetic navigation for bronchoscopy guidance may be valuable in the diagnosis of SPLL when conventional bronchoscopy fails.

In the present study, the authors evaluated the efficacy of EBG in a population of subjects who had arrived in a diagnostic cul-de-sac. These patients were not good candidates for surgery and previous diagnostic procedures, including bronchoscopy, TBNA or TTNA, had not been diagnostic. This population is illustrative of the limitations that exist in the diagnosis and treatment of pulmonary nodules in medically nonoperable patients. Surgery is associated with a high incidence of post-operative mortality and morbidity in these patients 30, 31. Despite the progress that has been made, surgical interventions may not be appropriate for every patient with radiographic evidence of early stage lung cancer. In addition, other diagnostic procedures, such as TTNA, carry a risk of complications that can be substantial in patients with an already compromised respiratory or low performance status. Consequently, both diagnostic and treatment decisions for medically nonoperable patients with lung nodules are not straightforward. However, the prospect of therapy should be given to these patients. Advances in radiation oncology and locally ablative techniques have resulted in improved survival with a significant decrease in post-procedure mortality and morbidity 7, 32. On this basis, histopathological confirmation of malignancy is essential prior to the initiation of these alternative treatments. In the present study, EGB successfully established a diagnosis in the majority of patients in this population. Moreover, in agreement with the results of earlier studies 22–24 serious complications did not occur. Thus, EGB can be a valuable diagnostic tool in the investigation of pulmonary nodules and may offer an alternative to surgical treatment in medically nonoperable patients.

The effect of electromagnetic navigational accuracy on SPLL biopsy results has not been evaluated until now. Although Gildea et al. 24 recently reported an excellent yield of EGB in the diagnosis of parenchymal and mediastinal lung lesions, additional fluoroscopic guidance was used systematically before biopsy. In this respect, the present study is the first to evaluate the accuracy of this technique in SPLL diagnosis without the help of additional fluoroscopic guidance. Moreover, it demonstrates a relationship between a measure of the navigational accuracy and biopsy results. The current findings suggest that the diagnostic yield of EGB may be affected by CT-to-body divergence rather than the size or location of the lesion. The EGB yield was found to be significantly lower when CT-to-body divergence was >4 mm.

CT-to-body divergence is unavoidable as EBG is not a real-time navigational system and this may be one of its current drawbacks. EBG yield is based on the reconstructed positioning as generated by the computerised system from the three-dimensional CT data and the registration process. Therefore, the bronchial relationships of a nodule may differ from fibreoptic endoscopy to CT acquisition and concurrent reformations. In addition, the differences in pulmonary volumes between endobronchial navigation and CT acquisition may result in variation in bronchial lengths and obliquities. However, these differences could be obviated in the near future with the application of CT with ultra-fast temporal resolution and/or respiratory gating.

In the present study, despite efforts to approach the target as closely as possible, the mean distance achieved from the centre of the target was 8.7 mm. This is most likely to be due to the progressive narrowing and branching of the bronchial tree. Although this difference did not significantly affect the results, it remains to be seen whether further improvements in equipment and software can overcome problems related to the architecture of the bronchial tree and further ameliorate the yield of EBG.

In the present study, no significant learning curve related to the technique was observed; the diagnostic accuracy during the first sessions of EBG was not significantly lower than that achieved during last session. EGB is not a cumbersome technique. Providing a previous experience in flexible bronchoscopy, EGB can be easily learnt.

As a large bronchoscope is needed for EBG, and the technique involves more manipulations than conventional bronchoscopy, the current patients underwent this procedure under anaesthesia in order to increase their comfort. Hence, the present results are not likely to be affected by cough or body movement. In addition, it is questionable whether respiration-induced movement significantly affects the yield of EGB 22–24. The present findings indirectly suggest that the opposite is the case. Since respiration-induced movement is larger in the caudal and peripheral parts of lungs than in the apical and central parts, a lower diagnostic yield would be expected in apical-central lesions. However, no significant association between the diagnostic yield of the technique and location of the lesion was observed.

In the present study, 8.5±0.7 biopsies were attempted per lesion which is greater than that reported in most studies. On the one hand this may have contributed to the high accuracy rate of this study but, on the other hand, makes a comparison with other studies difficult. However, a large number of biopsies were attempted because sampling issues may have a major role in the misdiagnosis in lung lesions cases 33. In the current study not all the samples obtained were adequate for analysis by the pathology department. Specimens obtained by flexible bronchoscopy forceps may be of small size, damaged or contain crush artefacts and thus, may be of low quality and consequently offer limited interpretation 34. Moreover, random problems that may occur during specimen delivery or conservation are not unlikely in clinical practice. These type of drawbacks underline the fact that, despite all the sophisticated advances in endoscopical tissue sampling, the yield of a diagnostic method can be still affected by other confounding factors and the negative predictive value for malignancy may be low 35. Thus, the clinician must always continue to pursue a diagnosis if an EGB biopsy is negative or nondiagnostic, using all available diagnostic methods.

The pneumothorax rate in the current study (three out of 40) was similar to that reported in a previous study (two out of 60) 24, although additional fluoroscopic guidance was not used during bronchoscopy and, in addition, a large number of biopsies were performed per lesion. Two patients experienced asymptomatic pneumothoraces immediately after procedure and a third patient presented with symptomatic pneumothorax a few hours later. In this respect, attention should be paid to the occurrence of adverse events in the 24 hours following the procedure.

In summary, electromagnetic navigation bronchoscopy without additional fluoroscopic guidance is a safe and efficient technique for the diagnosis of peripheral pulmonary nodules. The overall diagnostic yield found in the present study is superior to rates reported in most previous studies performed for small peripheral pulmonary nodules with bronchoscopy. In contrast to fluoroscopy, this technique is not associated with radiation exposure. Furthermore, this technique has the potential of a substantial contribution in the early diagnosis and treatment of lung cancer, particularly in patients considered medically inoperable. However, the integrated navigation sensor and software improvements are necessary in order to improve navigational accuracy before the method is widely applied in clinical practice.

Footnotes

  • Supplementary data is available online at www.ersjournals.com

  • Received December 19, 2006.
  • Accepted February 27, 2007.
  • © ERS Journals Ltd

References

  1. ↵
    Smith RA, Glynn TJ. Epidemiology of lung cancer. Radiol Clin North Am 2000;38:453–470.
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    Henschke CI, Yankelevitz DF, Miettinen OS. International Early Lung Cancer Action Program Investigators. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. Arch Intern Med 2006;166:321–325.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    Sone S, Takashima S, Li F, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998;351:1242–1245.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    Henschke CI, McCauley DI, Yankelevitz DF, et al. Early lung cancer action project: a summary of the findings on baseline screening. Oncologist 2001;6:147–152.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005;235:259–265.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Manser RL, Wright G, Byrnes G, et al. Validity of the assessment of quality of life (AQoL) utility instrument in patients with operable and inoperable lung cancer. Lung Cancer 2006;53:217–229.
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Rowell NP, Williams CJ. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable) a systematic review. Thorax 2001;56:628–638.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Torrington KC, Kern JD. The utility of fiberoptic bronchoscopy in the evaluation of the solitary pulmonary nodule. Chest 1993;104:1021–1024.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Fletcher EC, Levin DC. Flexible fiberoptic bronchoscopy and fluoroscopically guided transbronchial biopsy in the management of solitary pulmonary nodules. West J Med 1982;136:477–483.
    OpenUrlPubMedWeb of Science
  10. ↵
    Baaklini W, Reinoso M, Gorin A, Sharafkaneh A, Manian P. Diagnostic yield of fiberoptic bronchoscopy in evaluating solitary pulmonary nodules. Chest 2000;117:1049–1054.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    Shure D, Fedullo PF. Transbronchial needle aspiration of peripheral masses. Am Rev Respir Dis 1983;128:1090–1092.
    OpenUrlPubMedWeb of Science
  12. ↵
    Geraghty PR, Kee ST, McFarlane G, Razavi MK, Sze DY, Dake MD. CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax rate. Radiology 2003;229:475–481.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    Kazerooni EA, Lim FT, Mikhail A, Martinez FJ. Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung. Radiology 1996;198:371–375.
    OpenUrlPubMedWeb of Science
  14. Ohno Y, Hatabu H, Takenaka D, et al. CT-guided transthoracic needle aspiration biopsy of small (< or = 20 mm) solitary pulmonary nodules. AJR Am J Roentgenol 2003;180:1665–1669.
    OpenUrlCrossRefPubMedWeb of Science
  15. ↵
    Kato R, Katada K, Anno H, Suzuki S, Ida Y, Koga S. Radiation dosimetry at CT fluoroscopy: physician's hand dose and development of needle holders. Radiology 1996;201:576–578.
    OpenUrlPubMedWeb of Science
  16. ↵
    Radke JR, Conway WA, Eyler WR, Kvale PA. Diagnostic accuracy in peripheral lung lesions: factors predicting success with flexible fiberoptic bronchoscopy. Chest 1979;76:176–179.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    Cortese DA, McDougall JC. Biopsy and brushing of peripheral lung cancer with fluoroscopic guidance. Chest 1979;75:141–145.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    Li H, Boiselle PM, Shepard J-AO, Trotman-Dickenson B, McLoud TC. Diagnostic accuracy and safety of CT-guided percutaneous needle aspiration biopsy of the lung: comparison of small and large pulmonary nodules. AJR Am J Roentgenol 1996;167:105–109.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    Laurent F, Michel P, Latrabe V, Tunon de Lara M, Marthan R. Pneumothoraces and chest tube placement after CT-guided transthoracic lung biopsy using a coaxial technique: incidence and risk factors. AJR Am J Roentgenol 1999;172:1049–1053.
    OpenUrlPubMedWeb of Science
  20. ↵
    Schwarz Y, Mehta AC, Ernst A, et al. Electromagnetic navigation during flexible bronchoscope. Respiration 2003;70:516–522.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    Herth FJ, Eberhardt R, Becker HD, Ernst A. Endobronchial ultrasound-guided transbronchial lung biopsy in fluoroscopically invisible solitary pulmonary nodules: a prospective trial. Chest 2006;129:147–150.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    Hautmann H, Schneider A, Pinkau T, Peltz F, Feussner H. Electromagnetic catheter navigation during bronchoscopy validation of a novel method by conventional fluoroscopy. Chest 2005;128:382–387.
    OpenUrlCrossRefPubMedWeb of Science
  23. ↵
    Schwarz Y, Greif J, Becker HD, Ernst A, Mehta A. Real-time electromagnetic navigation bronchoscopy to peripheral lung lesions using overlaid CT images: the first human study. Chest 2006;129:988–994.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    Gildea TR, Mazzone PJ, Karnak D, Meziane M, Mehta AC. Electromagnetic navigation diagnostic bronchoscopy: a prospective study. Am J Respir Crit Care Med 2006;174:982–989.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 2003;123: Suppl. 1 115S–128S.
    OpenUrlCrossRefPubMedWeb of Science
  26. ↵
    Shiner RJ, Rosenman J, Katz I, Reichart N, Hershko E, Yellin A. Bronchoscopic evaluation of peripheral lung tumors. Thorax 1988;43:887–889.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Gasparini S, Zuccatosta L, Zitti P, et al. Integration of TBNA and TCNA in the diagnosis of peripheral lung nodules. Influence on staging. Ann Ital Chir 1999;70:851–855.
    OpenUrlPubMed
  28. ↵
    Jain P, Fleming P, Mehta AC. Radiation safety for health care workers in the bronchoscopy suite. Clin Chest Med 1999;20:33–38.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    Katis K, Inglesos E, Zachariadis E, et al. The role of transbronchial needle aspiration in the diagnosis of peripheral lung masses or nodules. Eur Respir J 1995;8:963–966.
    OpenUrlAbstract
  30. ↵
    Ginsberg RJ, Hill LD, Eagan RT, et al. Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg 1983;86:654–658.
    OpenUrlPubMedWeb of Science
  31. ↵
    Wiener DC, Argote-Greene LM, Ramesh H, Audisio RA, Jaklitsch MT. Choices in the management of asymptomatic lung nodules in the elderly. Surg Oncol 2004;13:239–248.
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    Herrera LJ, Fernando HC, Perry Y, et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg 2003;125:929–937.
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    Nodit L, Balassanian R, Sudilovsky D, Raab SS. Improving the quality of cytology diagnosis: root cause analysis for errors in bronchial washing and brushing specimens. Am J Clin Pathol 2005;124:883–892.
    OpenUrlCrossRefPubMedWeb of Science
  34. ↵
    Aleva RM, Kraan J, Smith M, ten Hacken NH, Postma DS, Timens W. Techniques in human airway inflammation: quantity and morphology of bronchial biopsy specimens taken by forceps of three sizes. Chest 1998;113:182–185.
    OpenUrlPubMedWeb of Science
  35. ↵
    Shinagawa N, Yamazaki K, Onodera Y, et al. CT-guided transbronchial biopsy using an ultrathin bronchoscope with virtual bronchoscopic navigation. Chest 2004;125:1138–1143.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
View this article with LENS
Vol 29 Issue 6 Table of Contents
European Respiratory Journal: 29 (6)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions
D. Makris, A. Scherpereel, S. Leroy, B. Bouchindhomme, J-B. Faivre, J. Remy, P. Ramon, C-H. Marquette
European Respiratory Journal Jun 2007, 29 (6) 1187-1192; DOI: 10.1183/09031936.00165306

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Electromagnetic navigation diagnostic bronchoscopy for small peripheral lung lesions
D. Makris, A. Scherpereel, S. Leroy, B. Bouchindhomme, J-B. Faivre, J. Remy, P. Ramon, C-H. Marquette
European Respiratory Journal Jun 2007, 29 (6) 1187-1192; DOI: 10.1183/09031936.00165306
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Endobronchial ultrasound: new insight for the diagnosis of sarcoidosis
Show more Original Articles: Innovative bronchial diagnostics

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society